Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data. These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.
http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/
To read the journal article, click here.
More RSI News
Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments
Risk Sciences International (RSI) is pleased to announce in collaboration with the Ontario Centre for Climate Impacts and Adaptation Resources (OCCIAR), the public release of…
Risks of anticholinergic drugs
Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records…
Dr. Emma Hartnett Selected for JEMRA Roster of Scientific Experts
RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a…
Safety Profiles of Newer Contraceptives presented at meeting of Society of Reproductive Investigation
RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and…